Cargando…
Acute Conditioning of Antigen-Expanded CD8(+) T Cells via the GSK3β-mTORC Axis Differentially Dictates Their Immediate and Distal Responses after Antigen Rechallenge
SIMPLE SUMMARY: Expanded, antigen-experienced CD8(+) T cells are utilized in immunotherapy to treat infections and cancers. Antigen rechallenge of these cells leads to their re-expansion. The effector functions of re-expanded CD8(+) T cells are critical for their therapeutic efficacy. We found that...
Autores principales: | Taborska, Pavla, Stakheev, Dmitry, Svobodova, Hana, Strizova, Zuzana, Bartunkova, Jirina, Smrz, Daniel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7765077/ https://www.ncbi.nlm.nih.gov/pubmed/33327544 http://dx.doi.org/10.3390/cancers12123766 |
Ejemplares similares
-
CD4(+) T Cells of Prostate Cancer Patients Have Decreased Immune Responses to Antigens Derived From SARS-CoV-2 Spike Glycoprotein
por: Taborska, Pavla, et al.
Publicado: (2021) -
The WNT/β-catenin signaling inhibitor XAV939 enhances the elimination of LNCaP and PC-3 prostate cancer cells by prostate cancer patient lymphocytes in vitro
por: Stakheev, Dmitry, et al.
Publicado: (2019) -
SARS‐CoV‐2 spike glycoprotein‐reactive T cells can be readily expanded from COVID‐19 vaccinated donors
por: Taborska, Pavla, et al.
Publicado: (2021) -
Thapsigargin-Stimulated LAD2 Human Mast Cell Line Is a Potent Cellular Adjuvant for the Maturation of Monocyte-Derived Dendritic Cells for Adoptive Cellular Immunotherapy
por: Taborska, Pavla, et al.
Publicado: (2021) -
LL-37 as a Powerful Molecular Tool for Boosting the Performance of Ex Vivo-Produced Human Dendritic Cells for Cancer Immunotherapy
por: Stakheev, Dmitry, et al.
Publicado: (2022)